Searchable abstracts of presentations at key conferences in endocrinology

Endocrine Abstracts

Published by BioScientifica
Previous issue | Volume 49 | ECE2017 | Next issue

19th European Congress of Endocrinology

Lisbon, Portugal
20 May 2017 - 23 May 2017

Card image cap
20-23 May 2017, Lisbon, Portugal Further information

Guided Posters

Pituitary & endocrine Tumours

Previous section
Pituitary
Table of contents
Next section
Thyroid 1

ea0049gp185 | Pituitary & endocrine Tumours

Localization of benign insulinomas using glucagon-like peptide-1 receptor (GLP1-R) SPECT/CT and PET/CT and MRI in a prospective clinical study

ea0049gp186 | Pituitary & endocrine Tumours

24 hour urinary 5-hydroxyindoleacetic acid (5-HIAA) doubling-time (DT) is associated with disease-specific mortality (DSM) and progression-free survival (PFS) in patients with neuroendocrine tumors (NETs)

ea0049gp187 | Pituitary & endocrine Tumours

Pasireotide alone or in combination with cabergoline effectively controls urinary free cortisol levels: results from a prospective study in patients with Cushing’s disease (CAPACITY)

ea0049gp188 | Pituitary & endocrine Tumours

Vertebral fractures are prevalent among patients with acromegaly in spite of normal bone mineral density reflecting overall duration of disease regardless of biochemical control or cure

ea0049gp189 | Pituitary & endocrine Tumours

Evaluation of pituitary toxicity after radiotherapy for cerebral chondrosarcomas in adult patients

ea0049gp190 | Pituitary & endocrine Tumours

Safety of long-term growth hormone (GH) treatment in adults with GH deficiency (GHD): an analysis from the NordiNet® International Outcome Study

ea0049gp191 | Pituitary & endocrine Tumours

GH and IGF-1 levels at 12 weeks predict long-term responses to lanreotide Autogel in treatment-naïve acromegalic patients: post-hoc analyses from the PRIMARYS study

ea0049gp192 | Pituitary & endocrine Tumours

Long-term treatment with pegvisomant (Somavert®): Observations from 2090 acromegaly patients followed in ACROSTUDY

ea0049gp193 | Pituitary & endocrine Tumours

Amenorrhea without vasomotor symptoms in women over 40: A sign of pathological hyperprolactinemia?

ea0049gp194 | Pituitary & endocrine Tumours

Serotonin, ATRX and DAXX as differential diagnostic markers of neuroendocrine tumours (NETs) in the sellar region. An immunohistochemical study in a large series of pituitary adenomas and in a non-pituitary NET

ea0049gp195 | Pituitary & endocrine Tumours

Long-term follow-up of a family with a large AIP gene deletion: variable phenotypes and challenges in the management

ea0049gp196 | Pituitary & endocrine Tumours

Diagnosis of acromegaly: Sex and BMI are the major determinants of growth hormone suppression during oral glucose tolerance test (OGTT)

Published by BioScientifica

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more